Translations:Anti-obesity medication/8/ja: Difference between revisions

From Azupedia
Jump to navigation Jump to search
Created page with "===両方==== * アミリン類似物質はエネルギー摂取を減少させ、消費を増加させることができ、レプチン類似物質と組み合わせることで相乗効果を得ることができる。二重アミリンおよびカルシトニン受容体作動薬である、カグリリンチド、cagrilintide/semaglutide/ja|セマグルチドとの..."
(No difference)

Revision as of 19:20, 7 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Anti-obesity medication)
===Both===
*[[Amylin]] analogues can both reduce energy intake and increase expenditure and can usefully be combined with [[leptin]] analogues for synergistic effect. The [[dual amylin and calcitonin receptor agonist]] [[cagrilintide]], [[cagrilintide/semaglutide|in combination with semaglutide]], was more effective than semaglutide alone in promoting weight loss in clinical trials.
*[[Glucagon receptor agonist]]s both reduce energy intake and increase energy expenditure in humans. They can cause hyperglycemia so it is recommended to combine them with a hypoglycemic drug, such as a GLP-1 or GIP receptor agonist.

両方=